07:45 AM EDT, 07/29/2024 (MT Newswires) -- vTv Therapeutics ( VTVT ) shares slumped more than 45% pre-bell Monday after the company said Friday that the Food and Drug Administration has placed a clinical hold on its cadisegliatin clinical program for type 1 diabetes.

Iovance Biotherapeutics ( IOVA ) shares fell 10% following a 1.9% loss in the previous session.

Regencell Bioscience ( RGC ) shares dropped 2.4%, paring Friday's rally.

Price: 11.51, Change: -9.69, Percent Change: -45.71